Candriam SCA’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-715
| Closed | -$293K | – | 856 |
|
|
2018
Q3 | $293K | Hold |
715
| – | – | ﹤0.01% | 756 |
|
|
2018
Q2 | $386K | Hold |
715
| – | – | 0.01% | 723 |
|
|
2018
Q1 | $329K | Hold |
715
| – | – | 0.01% | 715 |
|
|
2017
Q4 | $479K | Hold |
715
| – | – | 0.01% | 686 |
|
|
2017
Q3 | $450K | Buy |
+715
| New | +$450K | 0.01% | 677 |
|
|
2017
Q2 | – | Sell |
-715
| Closed | -$536K | – | 719 |
|
|
2017
Q1 | $536K | Hold |
715
| – | – | 0.01% | 644 |
|
|
2016
Q4 | $701K | Hold |
715
| – | – | 0.02% | 572 |
|
|
2016
Q3 | $967K | Hold |
715
| – | – | 0.02% | 502 |
|
|
2016
Q2 | $626K | Sell |
715
-100
| -12% | -$87.6K | 0.02% | 528 |
|
|
2016
Q1 | $1.13M | Sell |
815
-85
| -9% | -$118K | 0.03% | 409 |
|
|
2015
Q4 | $1.66M | Buy |
900
+223
| +33% | +$412K | 0.04% | 326 |
|
|
2015
Q3 | $1.32M | Buy |
677
+52
| +8% | +$102K | 0.03% | 399 |
|
|
2015
Q2 | $1.42M | Hold |
625
| – | – | 0.03% | 402 |
|
|
2015
Q1 | $1.76M | Buy |
+625
| New | +$1.76M | 0.04% | 408 |
|